Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. [electronic resource]
- Vaccine Sep 2011
- 7188-96 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2011.05.079 doi
Animals Cell Line Haplorhini Humans Netherlands Poliovirus--genetics Poliovirus Vaccine, Inactivated--immunology Poliovirus Vaccine, Oral--immunology Technology Transfer Technology, Pharmaceutical--methods